Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Estrogen Replacement Therapy market likely to promulgate by the increase in demand for estrogen replacement therapy for treating women suffering from menopausal symptoms
Global Estrogen Replacement Therapy market estimated to grow with a significant rate during the forecast period, 2020-2027. It is owing to hormonal imbalance disorders in women, including menopause. These hormone levels get altered in women with growing age, leading to various disorders and diseases. Estrogen replacement therapy helps in preventing women's osteoporosis, a consequence of lowered estrogen levels. Estrogen therapy used to reduce the short-term changes of menopause, such as hot flashes, disturbed sleep, and vaginal dryness. Moreover, the increasing demand for Estrogen replacement theory to relieve the symptoms of the menopausal syndrome such as facial hot flashes and night sweats and growing uses of ERT for vaginal and vulvar atrophy in menopausal women will propel the global estrogen replacement therapy market in the projected periods.
ERT can improve the pain associated with sexual intercourse, one of the most common causes of sexual apathy in menopausal women. Estrogen therapy can apply to the skin, such as patches, gels, and sprays. These low dose estrogen pills, which are approved by the United States Food and Drug Administration (FDA) have been helpful for lower risks of blood clots and strokes than standard doses of estrogen pills. It reduces the risk of colon cancer. In addition, a growing need for Estrogen to protect against the bone-thinning disease and to treat vaginal symptoms and urinary symptoms into the body will fuel the global Estrogen replacement therapy market.
Dosages form Overview in the Global Estrogen Replacement Therapy Market
Based on dosages form, the global Estrogen Replacement Therapy market classified into Patches, Tablets, Gels/Creams, Suppositories, Implants, and Injections. The Tablets segment will lead the market on account of its help in relieving menopause symptoms, maintain vaginal health, helps ovary issues, and protect bones.
Routes of administration Overview in the Global Estrogen Replacement Therapy Market
Based on routes of administration, the global Estrogen Replacement Therapy market categorized into Oral, Topical, Subcutaneous Pellets, Injection, and Others. The oral segment likely to lead the market by 2027, based on easy availability as a vaginal ring, topical spray, cream, or gel. It is the most common form of ERT and reduces or resolves troublesome symptoms of menopause.
End-User Industry Overview in the Global Estrogen Replacement Therapy Market
Based on end-user, the global Estrogen replacement therapy market classified into Hospitals, Clinics, Pharmacy stores, and others. Hospitals segment expected to generate maximum revenue by 2027 due to the increase in the number of hospitals in developing countries along with rising awareness among women regarding the menopausal symptoms worldwide.
Regional Overview in the Global Estrogen Replacement Therapy Market
By geography, the Global Estrogen Replacement Therapy Market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America dominates the market based on rising disposables income level, improving health care awareness levels along with the surge in demand for Estrogen Replacement Therapy old aged women in these regions.
Global Estrogen Replacement Therapy Market: Competitive Landscape
Companies such as AbbVie, Inc., Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Novartis AG, Novo Nordisk A/S, Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. are the key players in the Global Estrogen Replacement Therapy Market.